GlassScriptPhysician profile
Allison Renee Mcallister
NPI 1902138456
$10,422.72
in general payments reported to CMS, 2019-2025
55 companies · $2,414 in 2025
The $2,414 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,562 · 2022: $2,237 · 2023: $2,066 · 2024: $2,143 · 2025: $2,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,370 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,369.84 |
| Education | $253.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $941.41 | 2021-2025 | Trodelvy |
| Novartis Pharmaceuticals Corporation | $842.79 | 2021-2025 | |
| Daiichi Sankyo INC. | $691.18 | 2021-2025 | Enhertu, Datroway, Injectafer |
| Beigene USA, INC. | $594.43 | 2021-2025 | Brukinsa |
| Incyte Corporation | $587.47 | 2021-2025 | Monjuvi, Zynyz, Monjuvi |
| Celgene Corporation | $468.88 | 2022-2025 | Reblozyl, Pomalyst, Opdualag |
| Asd Specialty Healthcare, LLC | $459.67 | 2021-2025 | |
| Abbvie INC. | $441.62 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $436.36 | 2021-2025 | Eliquis, Opdivo, Krazati |
| Genentech USA, INC. | $352.70 | 2021-2024 | Tecentriq, Phesgo, Polivy |
| Amgen INC. | $310.06 | 2021-2022 | |
| Pfizer INC. | $303.42 | 2021-2025 | |
| Astellas Pharma US INC | $291.27 | 2021-2023 | Xtandi |
| Genzyme Corporation | $257.43 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $241.43 | 2021-2025 | Libtayo, Lynozyfic |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Mcallister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.